Physician

David G. Brodland, M.D.

According to 2025 Medicare claims, David Brodland, M.D. (NPI: 1114980422) practices dermatology in the Pittsburgh, PA market, with the plurality of this provider's patient population coming from Allegheny, PA. This provider's primary affiliated billing organization is ZITELLI & BRODLAND PC (NPI: 1184790099; TIN: 251549973) and primary practice location at 15025-3739.

Brodland's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 626 traditional Medicare patients, billed 3,514 HCPCS/CPT codes, and received $503,330 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 71 prescription claims across 47 beneficiaries totaling $1,021 in drug costs, led by Triamcinolone Acetonide (Triamcinolone Acetonide). Open Payments data shows 2 records totaling $143. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $9,657 and ending at $1,021. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$252K$503K2015 Medicare payment: $410,618 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $446,287 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $473,203 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $408,924 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $434,255 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $460,961 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $428,693 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $389,810 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $421,068 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $503,330 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20155774,620$410,618
20166495,107$446,287
20176295,351$473,203
20186014,419$408,924
20196674,668$434,255
20206564,840$460,961
20216984,867$428,693
20227355,348$389,810
20235092,727$421,068
20246263,514$503,330

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$26K$53K2015 Drug cost: $9,657 (USD; Tot_Drug_Cst)2016 Drug cost: $9,000 (USD; Tot_Drug_Cst)2017 Drug cost: $7,041 (USD; Tot_Drug_Cst)2018 Drug cost: $3,784 (USD; Tot_Drug_Cst)2019 Drug cost: $35,594 (USD; Tot_Drug_Cst)2020 Drug cost: $24,005 (USD; Tot_Drug_Cst)2021 Drug cost: $52,730 (USD; Tot_Drug_Cst)2022 Drug cost: $1,249 (USD; Tot_Drug_Cst)2023 Drug cost: $1,836 (USD; Tot_Drug_Cst)2024 Drug cost: $1,021 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201588125$9,657
201673109$9,000
201763100$7,041
20185985$3,784
201966103$35,594
20205881$24,005
202165104$52,730
20223344$1,249
20234460$1,836
20244771$1,021

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks325415$423
17312Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks147217$284
88331Pathology examination of specimen during surgery, first tissue block244445$69
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more353456$60
11102Biopsy of related skin growth, first growth148170$54

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Triamcinolone AcetonideTriamcinolone Acetonide17470$104

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$143Kerecis Limited
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for David G. Brodland, M.D.?

Tedicare shows public-source Medicare data for David G. Brodland, M.D. (NPI 1114980422), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David G. Brodland, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to David G. Brodland, M.D.?

David G. Brodland, M.D. is linked to ZITELLI & BRODLAND PC (billing NPI 1184790099) in the available physician profile data.

Does David G. Brodland, M.D. have Open Payments data?

David G. Brodland, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.